Globant S.A. (GLOB)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 814 | 1,297 | 1,780 | 2,096 | 2,416 | 2,455 | 2,451 | 2,445 |
| Operating profit | $m | 172 | 202 | ||||||
| Net profit | $m | 54 | 96 | 149 | 159 | 166 | 103 | 113 | 266 |
| EPS reported | $ | 2.29 | 2.55 | ||||||
| Operating cashflow per share | $ | 6.24 | 7.64 | ||||||
| Capex per share | $ | 0.43 | 0.21 | ||||||
| FCF per share | $ | 5.81 | 7.43 | ||||||
| Free cash flow | $m | 261 | 318 | ||||||
| Net debt | $m | 116 | 253 | ||||||
| Book value equity | $m | 2,094 | 2,114 | ||||||
| Book value per share | $ | 46.52 | 48.89 | ||||||
| Number of shares | m | 45.01 | 43.23 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 28.55 | 13.25 | ||||||
| P/B LTM | x | 1.40 | 1.39 | ||||||
| P/S LTM | x | 1.20 | 1.20 | ||||||
| P/FCF LTM | x | 11.25 | 9.22 | ||||||
| EV/EBITDA LTM | x | 10.58 | 10.33 | ||||||
| EV/Sales LTM | x | 1.29 | 0.80 | ||||||
| Earnings Yield LTM | % | +3.50% | +7.55% | ||||||
| FCF Yield | % | +8.89% | +10.84% | ||||||
| Quality | |||||||||
| ROE | % | +4.92% | +5.33% | ||||||
| ROIC | % | +4.61% | +5.43% | ||||||
| Operating margin | % | +7.00% | +8.23% | ||||||
| Gross margin | % | +35.00% | +32.26% | ||||||
| FCF/Sales | % | +10.64% | +12.99% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -38.44% | -31.45% | ||||||
| Sales Growth YoY | % | +1.62% | +1.47% | ||||||
| Net Income Growth YoY | % | -37.90% | -31.57% | ||||||
| FCF Growth | % | +18.20% | +44.12% | ||||||
| Operating Profit Growth | % | -23.82% | -10.50% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.55 | 0.62 | ||||||
| Net Debt/EBITDA | x | 0.77 | 1.15 | ||||||
| EBIT/Net interest | x | 4.23 | 5.69 | ||||||
| Net debt/market cap | % | +12.48% | +26.14% | ||||||
| Net debt/Equity | x | 0.06 | 0.12 | ||||||
| Gross debt/equity | x | 0.23 | 0.25 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development lifecycle; GUT Studio, which allows clients to better connect brands to end-consumers through experiential marketing; and Enterprise Studio, which leverages tailored technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, enabling industry-specific fine-tuning, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows that operate across systems, teams, and physical environments. Further, it provides various agentic suites, including GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, which enhances marketing, communications, and advertising with AI at the core, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. The company has a collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development lifecycle; GUT Studio, which allows clients to better connect brands to end-consumers through experiential marketing; and Enterprise Studio, which leverages tailored technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, enabling industry-specific fine-tuning, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows that operate across systems, teams, and physical environments. Further, it provides various agentic suites, including GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, which enhances marketing, communications, and advertising with AI at the core, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. The company has a collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free